Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy.
Steenbeek MP, van Bommel MHD, Harmsen MG, Hoogerbrugge N, van Doorn HC, Keurentjes JHM, van Beurden M, Zweemer RP, Gaarenstroom KN, Penders CGJ, Brood-van Zanten MMA, Vos MC, Piek JM, van Lonkhuijzen LRCW, Apperloo MJA, Coppus SFPJ, IntHout J, de Hullu JA, Hermens RPMG.
Steenbeek MP, et al. Among authors: keurentjes jhm.
Gynecol Oncol. 2021 Nov;163(2):371-377. doi: 10.1016/j.ygyno.2021.08.019. Epub 2021 Aug 27.
Gynecol Oncol. 2021.
PMID: 34456057
Free article.
Clinical Trial.